# Mass Balance Study of FYU-981

> **NCT02901366** · PHASE2 · COMPLETED · sponsor: **Fuji Yakuhin Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Healthy Male Subjects

## Interventions

- **DRUG:** 14C-FYU-981

## Key facts

- **NCT ID:** NCT02901366
- **Lead sponsor:** Fuji Yakuhin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-01
- **Final completion:** 2018-07
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02901366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02901366, "Mass Balance Study of FYU-981". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02901366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*